Cerus Corporation
CERSNASDAQHealthcare● Active
$2.60
$-0.11(-4.06%)
Market Cap$520959332
P/E Ratio—
52W High$3.15
52W Low$1.15
Cerus Corporation (CERS) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
CERS · earnings · updated Jun 9, 2026
Latest Earnings
Q2 FY2026Report Date: Apr 30, 2026EPS Actual
-$0.01
Est. -$0.03 · +66.7%
Revenue
$0.06B
Est. $0.06B · +7.6%
Fiscal Period
Q2 FY2026
FY ends December
Report Date
Apr 30, 2026
After Market Close
▲ Beat EPS▲ Beat Revenue✓ 3-Quarter EPS Beat Streak
CERS reports quarterly as a NASDAQ-listed Medical - Devices company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
84
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
$-0.06
Rev. $1.94B
Days Away84
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.$-0.06
Rev. Est.$1.94B
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| ◌ Q3 FY2026 | Aug 4, 2026 | -$0.01 | — | — | — | $0.06B | — |
| ▲ Q2 FY2026 | Apr 30, 2026 | -$0.03 | -$0.01 | +66.7% | $0.06B | $0.06B | +7.6% |
| — Q1 FY2026 | Mar 2, 2026 | -$0.01 | -$0.01 | +0.0% | $0.06B | $0.06B | +4.5% |
| ▲ Q4 FY2025 | Nov 6, 2025 | -$0.02 | -$0.00 | +99.5% | $0.05B | $0.06B | -11.1% |
| ▼ Q3 FY2025 | Aug 5, 2025 | -$0.02 | -$0.03 | -50.0% | $0.05B | $0.05B | -3.4% |
| ▲ Q2 FY2025 | May 1, 2025 | -$0.05 | -$0.04 | +20.0% | $0.04B | $0.05B | -8.9% |
| — Q1 FY2025 | Feb 20, 2025 | -$0.01 | -$0.01 | +0.0% | $0.05B | $0.05B | -4.0% |
| ▼ Q4 FY2024 | Oct 30, 2024 | -$0.01 | -$0.02 | -33.3% | $0.05B | $0.05B | -9.2% |
Q3 FY2026
Aug 4, 2026
EPS Actual
—
EPS Est.
-$0.01
EPS Surpr.
—
Revenue
—
Q2 FY2026
Apr 30, 2026Beat
EPS Actual
-$0.01
EPS Est.
-$0.03
EPS Surpr.
+66.7%
Revenue
$0.06B
Q1 FY2026
Mar 2, 2026
EPS Actual
-$0.01
EPS Est.
-$0.01
EPS Surpr.
+0.0%
Revenue
$0.06B
Q4 FY2025
Nov 6, 2025Beat
EPS Actual
-$0.00
EPS Est.
-$0.02
EPS Surpr.
+99.5%
Revenue
$0.05B
Q3 FY2025
Aug 5, 2025Miss
EPS Actual
-$0.03
EPS Est.
-$0.02
EPS Surpr.
-50.0%
Revenue
$0.05B
Q2 FY2025
May 1, 2025Beat
EPS Actual
-$0.04
EPS Est.
-$0.05
EPS Surpr.
+20.0%
Revenue
$0.04B
Q1 FY2025
Feb 20, 2025
EPS Actual
-$0.01
EPS Est.
-$0.01
EPS Surpr.
+0.0%
Revenue
$0.05B
Q4 FY2024
Oct 30, 2024Miss
EPS Actual
-$0.02
EPS Est.
-$0.01
EPS Surpr.
-33.3%
Revenue
$0.05B
Analyst Estimates
Limited analyst coverage (fewer than 3 analysts). Estimates may not reflect market consensus.
EPS Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2027 | $0.01 | $0.01 | $0.01 | 1 |
| Q3 FY2027 | $0.01 | $0.01 | $0.01 | 1 |
| Q2 FY2027 | $-0.01 | $-0.01 | $-0.01 | 1 |
| Q1 FY2027 | $-0.01 | $-0.01 | $-0.01 | 1 |
| Q4 FY2026 | $-0.00 | $-0.00 | $-0.00 | 1 |
| Q3 FY2026 | $-0.01 | $-0.01 | $-0.01 | 1 |
Revenue Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2027 | $0.1B | $0.1B | $0.1B | 1 |
| Q3 FY2027 | $0.1B | $0.1B | $0.1B | 2 |
| Q2 FY2027 | $0.1B | $0.1B | $0.1B | 2 |
| Q1 FY2027 | $0.1B | $0.1B | $0.1B | 1 |
| Q4 FY2026 | $0.1B | $0.1B | $0.1B | 2 |
| Q3 FY2026 | $0.1B | $0.1B | $0.1B | 3 |
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| ▲ Q2 FY2026 | Apr 30, 2026 | +66.7% | $1.92 | $2.03 | +5.73% |
| ▲ Q1 FY2026 | Mar 2, 2026 | +0.0% | $2.56 | $2.53 | -1.17% |
| ▲ Q4 FY2025 | Nov 6, 2025 | +99.5% | $1.45 | $1.41 | -2.76% |
| ▼ Q3 FY2025 | Aug 5, 2025 | -50.0% | $1.30 | $1.28 | -1.54% |
| ▲ Q2 FY2025 | May 1, 2025 | +20.0% | $1.32 | $1.30 | -1.52% |
| ▲ Q1 FY2025 | Feb 20, 2025 | +0.0% | $1.81 | $1.74 | -3.87% |
| ▼ Q4 FY2024 | Oct 30, 2024 | -33.3% | $1.70 | $1.72 | +1.18% |
| ▼ Q3 FY2024 | Aug 1, 2024 | -25.0% | $2.26 | $2.04 | -9.73% |
Q2 FY2026+5.73%
Report Date
Apr 30, 2026
EPS Beat/Miss
+66.7%
Price Before
$1.92
Price After
$2.03
Q1 FY2026-1.17%
Report Date
Mar 2, 2026
EPS Beat/Miss
+0.0%
Price Before
$2.56
Price After
$2.53
Q4 FY2025-2.76%
Report Date
Nov 6, 2025
EPS Beat/Miss
+99.5%
Price Before
$1.45
Price After
$1.41
Q3 FY2025-1.54%
Report Date
Aug 5, 2025
EPS Beat/Miss
-50.0%
Price Before
$1.30
Price After
$1.28
Q2 FY2025-1.52%
Report Date
May 1, 2025
EPS Beat/Miss
+20.0%
Price Before
$1.32
Price After
$1.30
Q1 FY2025-3.87%
Report Date
Feb 20, 2025
EPS Beat/Miss
+0.0%
Price Before
$1.81
Price After
$1.74
Q4 FY2024+1.18%
Report Date
Oct 30, 2024
EPS Beat/Miss
-33.3%
Price Before
$1.70
Price After
$1.72
Q3 FY2024-9.73%
Report Date
Aug 1, 2024
EPS Beat/Miss
-25.0%
Price Before
$2.26
Price After
$2.04
Avg Beat Reaction-0.72%
Avg Miss Reaction-3.36%
Beat Rate5 / 8 quarters
Largest Move-9.73% (Q3 FY2024)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: CERS ends December
Cerus Corporation (CERS) most recently reported earnings on April 30, 2026 for Q2 FY2026, posting EPS of $-0.01 — beating the analyst consensus of $-0.03 by +66.7%. CERS has beaten EPS estimates for 3 consecutive quarters. The next CERS earnings date is expected around September 1, 2026.
Each quarter, investors track CERS earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. CERS revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
CERS's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
CERS earnings · 5 questionsCerus Corporation's next earnings report is expected around September 1, 2026. CERS typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; CERS historically reports after market close (AMC).
CERS earnings datewhen is CERS earningsCERS next earnings datewhen does CERS report earningsCERS earnings calendar
▸ Source: FMP · Cerus Corporation SEC filings · US GAAP · Cerus Corporation SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 9, 2026